Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Avanir Pharmaceuticals
Current Parent Company: Otsuka Pharmaceutical
Parent at the Time of the Penalty Announcement:  subscribe to see this data field
Penalty: $7,000,000
Year: 2019
Date: September 30, 2019
Offense Group: government-contracting-related offenses
Primary Offense: False Claims Act and related
Secondary Offense: off-label or unapproved promotion of medical products
Violation Description: Avanir Pharmaceuticals agreed to pay $7 million to the states to resolve civil False Claims Act relating to payments made to physicians to induce prescriptions of its drug Nuedexta. This was part of a larger $115 million civil and criminal settlement involving the federal governmen (see separate entry).
Level of Government: state
Action Type: agency action
Agency: Multistate Attorneys General Case
Civil or Criminal Case: civil
HQ Country of Current Parent: Japan
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data: (click here)
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.